Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

New research opens the door to more accessible insulin storage options

A new Cochrane review has found that insulin can be kept at room temperature for months without losing potency, offering hope to people living with diabetes in regions with limited access to healthcare or stable powered refrigeration.

2 Nov 2023

Existing drug could be repurposed to treat type 1 diabetes, study suggests

Type 1 diabetes is an autoimmune disease that causes the body's immune system to attack and destroy insulin-producing beta cells in the pancreas. Traditional management of type 1 diabetes has primarily involved replacing the missing insulin with injections which, though effective, can be expensive and burdensome.

1 Nov 2023

Repurposing of DFMO could lead to innovative therapies for type 1 diabetes

A recent study led by Indiana University School of Medicine in collaboration with the University of Chicago Medicine presents exciting future possibilities for the management of type 1 diabetes and the potential reduction of insulin dependency.

1 Nov 2023

Two-year diabetic eye screening could lead to treatment delays and sight loss

Extending the annual screen to two years for people in England considered at low risk of diabetic eye disease could lead to critical treatment delays and sight loss, according to research led by St George's, University of London and Moorfields Eye Hospital NHS Foundation Trust and involving Kingston University, London researchers and academics.

31 Oct 2023

How does the Mediterranean diet impact insulin resistance and sensitivity in obese individuals?

Researchers evaluate the associations between adherence to the Mediterranean diet, insulin secretion, resistance, and sensitivity in obese individuals.

30 Oct 2023

Low-cost anti-inflammatory hydrogel could help treat chronic skin lesions in people with diabetes

Researchers in São Paulo state, Brazil, have developed a low-cost anti-inflammatory hydrogel that in future could help treat chronic skin lesions such as those often seen in people with diabetes.

27 Oct 2023

Study: Extending diabetic eye screen to 2 years could risk critical treatment delays and sight loss

Extending the annual screen by a year for people in England considered to be at low risk of diabetic eye disease (diabetic retinopathy) could risk critical treatment delays and/or sight loss, suggests a large, real world data study, published online in the British Journal of Ophthalmology.

25 Oct 2023

Early eating habits shape celiac disease risk in young kids, study shows

This long-term study reveals that dietary patterns in the first two years of life can significantly influence the risk of developing celiac disease autoimmunity (CDA) and celiac disease in genetically predisposed children. High intake of vegetable fats and milk at 9 months reduced CDA risk, while at 24 months, certain foods like wheat and vegetable fats increased the risk, emphasizing the role of non-gluten dietary factors.

17 Oct 2023

Oral diabetes and obesity meds danuglipron and orforglipron show promise but have gastrointestinal drawbacks

New orally-administered GLP-1 receptor agonists danuglipron and orforglipron show promise in treating type 2 diabetes and obesity, according to a systematic review. While effective in glycemic control and weight reduction, these drugs come with gastrointestinal side effects that may lead to treatment discontinuation.

17 Oct 2023

Closed-loop insulin delivery improves pregnancy experiences for women with type 1 diabetes

A new study endorses closed-loop use in type 1 diabetes pregnancy and highlights how the technology can facilitate positive pregnancy experiences.

12 Oct 2023

Hybrid closed-loop technology could be game-changing for pregnant women with type 1 diabetes

For pregnant women with type 1 diabetes, a technology giving insulin doses as informed by a smartphone algorithm, helps them better manage their blood sugars, compared to traditional insulin pumps or multiple daily injections, according to a new randomized trial published in The New England Journal of Medicine and presented at the European Association for the Study of Diabetes (EASD) meeting.

10 Oct 2023

The critical role of model interpretation in diabetes decision support systems

The importance of tools used to interpret the output of predictive models in type 1 diabetes (T1D) management.

10 Oct 2023

The potential benefits of ribavirin and pleconaril treatment on type 1 diabetes

Researchers investigate whether ribavirin and pleconaril could stimulate endogenous insulin production among individuals with incident type 1 diabetes.

8 Oct 2023

A telehealth model to support remote diabetes self-care

Researchers develop and test the effectiveness of a Virtual Diabetes Specialty Clinic (VDiSC), a virtual model facilitating comprehensive diabetes care remotely.

6 Oct 2023

New technology helps pregnant women with type 1 diabetes to better manage blood sugar levels

For pregnant women with type 1 diabetes, a technology giving insulin doses, as informed by a smartphone algorithm, helps them better manage their blood sugars compared with traditional insulin pumps or multiple daily injections, according to a new randomized trial published in The New England Journal of Medicine (NEJM) and presented at the European Association for the Study of Diabetes (EASD) meeting in Hamburg (2-6 October).

5 Oct 2023

Automated insulin delivery could be a game-changer for pregnant women with type 1 diabetes

Automated insulin delivery should be rolled out to pregnant women with type 1 diabetes - according to researchers at the University of East Anglia.

5 Oct 2023

The cut-off for HbA1c-based diagnosis of diabetes may be too high in women

Researchers compare the distribution of glycated hemoglobin (HbA1c) levels in premenopausal women and men of the same age.

4 Oct 2023

Antiviral treatment emerges as a potential game-changer in curbing type 1 diabetes progression

New research from the University of Oslo reveals antiviral drugs could help preserve insulin production in children newly diagnosed with type 1 diabetes, potentially slowing down or even preventing the disease. The study, building on earlier findings linking enterovirus to type 1 diabetes, showed that antiviral treatment led to maintained insulin production, proposing a new therapeutic avenue to treat and mitigate the progression of type 1 diabetes.

3 Oct 2023

Universal screening: A game-changer in early detection and management of type 1 diabetes

Dr. Emily K. Sims discusses the crucial role of universal type 1 diabetes (T1D) screening in early detection, especially in individuals without a family history, at the EASD Annual Meeting. This proactive approach, aligned with disease-modifying therapies, aims to prevent severe diabetic ketoacidosis episodes, marking a stride towards better management of T1D.

3 Oct 2023

Stem cell-derived islet cell therapy shows promise for type 1 diabetes

Six adults with type 1 diabetes (T1D) treated with stem cell-derived islet cells (VX-880) have shown improved blood sugar control with three participants achieving insulin independence, according to new research being presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Hamburg (2-6 Oct).

3 Oct 2023

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

New research opens the door to more accessible insulin storage options

Existing drug could be repurposed to treat type 1 diabetes, study suggests

Repurposing of DFMO could lead to innovative therapies for type 1 diabetes

Two-year diabetic eye screening could lead to treatment delays and sight loss

How does the Mediterranean diet impact insulin resistance and sensitivity in obese individuals?

Low-cost anti-inflammatory hydrogel could help treat chronic skin lesions in people with diabetes

Study: Extending diabetic eye screen to 2 years could risk critical treatment delays and sight loss

Early eating habits shape celiac disease risk in young kids, study shows

Oral diabetes and obesity meds danuglipron and orforglipron show promise but have gastrointestinal drawbacks

Closed-loop insulin delivery improves pregnancy experiences for women with type 1 diabetes

Hybrid closed-loop technology could be game-changing for pregnant women with type 1 diabetes

The critical role of model interpretation in diabetes decision support systems

The potential benefits of ribavirin and pleconaril treatment on type 1 diabetes

A telehealth model to support remote diabetes self-care

New technology helps pregnant women with type 1 diabetes to better manage blood sugar levels

Automated insulin delivery could be a game-changer for pregnant women with type 1 diabetes

The cut-off for HbA1c-based diagnosis of diabetes may be too high in women

Antiviral treatment emerges as a potential game-changer in curbing type 1 diabetes progression

Universal screening: A game-changer in early detection and management of type 1 diabetes

Stem cell-derived islet cell therapy shows promise for type 1 diabetes

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in